Childhood Cancer

You are here

Acute Myeloid Leukemia (AML)

Childhood acute myeloid leukemia (AML) is a cancer of the myeloid cells that form white blood cells, red blood cells or platelets. AML is the second most common form of childhood leukemia. View the 2020 Impact Report.

 

Latest Acute Myeloid Leukemia (AML) grants

Leonard Zon, MD, Principal Investigator
Boston Children's Hospital
Crazy 8 Awards, Awarded 2021
Wenbin Xiao, MD/PhD, Principal Investigator
Memorial Sloan-Kettering Cancer Center
RUNX1 Early Career Investigator Grants, Awarded 2020
Lucio Castilla, PhD, Principal Investigator
University of Massachusetts Medical School
Familial RUNX1 Research Grants, Awarded 2020

Latest Acute Myeloid Leukemia (AML) blog posts

As the Alex’s Lemonade Stand Foundation (ALSF) Director of Science, I work to evaluate our funded research projects to track progress and find gaps in funding so that we can direct more research dollars to the largest areas of need, and to... more
When Lilly faced surgery after relapsing, her family made the decision to donate extra tumor tissue to research instead of throwing it away. 

“We hope that Lilly’s neuroblastoma tumor can be some small part of helping other children who... more
Every day, everywhere, children are diagnosed with cancer. Right now, children are in hospitals receiving frontline treatment following a diagnosis. Other children are beginning a clinical trial following a relapse. Still others face long-... more